Thermo Fisher Scientific
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Stock Symbol: TMO
1632 articles about Thermo Fisher Scientific
-
Thermo Fisher Scientific Introduces Highly Sensitive Research Assays for Measurable Residual Disease Detection in Myeloid Malignancies
8/4/2022
Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD).
-
Automated Dried Spot Sampling and Analysis System Redefines Workflow
8/3/2022
Thermo Fisher Scientific Inc., the world leader in serving science, enables clinical research, toxicology and anti-doping laboratories performing dried spot sampling and analysis to utilize a new automated sample prep and ultra-high-performance liquid chromatography system to improve efficiency, robustness, sensitivity and sample traceability.
-
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
8/3/2022
Thermo Fisher Scientific Inc. and Structura Biotechnology Inc. today announced a collaboration to make available a new single particle analysis software solution, a version of Structura’s CryoSPARC Live.
-
Thermo Fisher Scientific Opens Oncomine Clinical Research Grant Call for Submissions and Announces Latest Awardees
8/1/2022
As part of its continued commitment to expand the benefits of next-generation sequencing (NGS), Thermo Fisher Scientific is now accepting submissions for the fifth round of the Oncomine Clinical Research Grant program.
-
New Cryo-Plasma Focused Ion Beam to Streamline Cellular Cryo-Electron Tomography Research
8/1/2022
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research.
-
Thermo Fisher Scientific Reports Second Quarter 2022 Results
7/28/2022
Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the second quarter ended July 2, 2022.
-
The U.S. Attorney’s Office was busy indicting nine people for charges related to insider trading. Some charges were unrelated, but three were specific to the biopharma industry.
-
Thermo Fisher Scientific Showcases New Clinical and Research Lab Solutions at AACC 2022
7/25/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.
-
Sanofi, Certara, Pfizer and Thermo Fisher are facing hiring challenges head-on with a common strategy: upskilling programs. They use these programs to fill open roles while training and retaining existing talent.
-
Thermo Fisher Scientific Declares Quarterly Dividend - July 07, 2022
7/7/2022
Thermo Fisher Scientific Inc., the world leader in serving science, announced that on July 7, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on October 14, 2022, to shareholders of record as of September 15, 2022.
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022
7/5/2022
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022.
-
FDA Clears Thermo Scientific EliA RNA Pol III and EliA Rib-P Tests for Use in U.S.
6/9/2022
Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE).
-
Thermo Fisher Scientific’s Clinical Research Business Named Clinical Research Company of the Year for Third Consecutive Year
6/8/2022
The PPD clinical research business of Thermo Fisher Scientific has been named Clinical Research Company of the Year at the 2022 PharmaTimes Clinical Researcher of the Year International competition held recently in London.
-
Updated Software Solutions Offer Increased Productivity and Data Confidence
6/6/2022
Thermo Fisher Scientific Inc., the world leader in serving science, has released new software to scientists in biopharmaceutical, proteomics, and small molecule settings to enable more comprehensive analysis of their data.
-
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
6/6/2022
The company announces new mass spectrometry instruments, workflows, software and industry collaborations during ASMS 2022 Conference.
-
Thermo Fisher Scientific Collaborates with TransMIT GmbH on a High-Performance Orbitrap Mass Spectrometry Imaging Platform
6/6/2022
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues.
-
Novel Mass Spectrometry Solution Simplifies Insight Gathering into Macromolecular Complexes
6/6/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is providing proteomics and biopharmaceutical laboratories working in drug discovery and R&D applications with an innovative mass spectrometry solution that, for the first time, unlocks the ability to clearly decipher complex mixtures of large macromolecules.
-
New Sample Preparation System Improves Proteomics Research Productivity
6/6/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is helping proteomics researchers increase productivity and free up time for more value-added activities when generating high quality samples for analysis, using a new automated sample preparation system that integrates within any LC-MS workflow.
-
Expanded Liquid Chromatography-Mass Spectrometry Platform Provides All-in-One Toxicology Solution
6/6/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is providing forensic toxicologists, clinical research toxicologists, employee drug testing facilities, and wellness organizations with an all-in-one liquid chromatography-mass spectrometry toxicology solution to keep pace with the ever-changing landscape of emerging and illicit drugs.
-
Advanced HPLC Column Delivers Improved Separation Performance and Protein Identification in Comprehensive New Proteomics Workflow
6/6/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is providing proteomics and biopharmaceutical research laboratories with a new micro-pillar array column as part of an end-to-end LC-MS workflow that will simplify complex bottom-up proteomics analyses.